These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 33727952)

  • 1. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
    Fan C; Du J; Liu N
    Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
    Yang B; Wang Y; Liu T; Zhang M; Luo T
    Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
    Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
    Front Immunol; 2021; 12():657950. PubMed ID: 33936088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
    BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
    Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
    J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.